Keyphrases
High Dose
100%
Response Rate
100%
Hepatitis B Vaccine
100%
Antibody Response
100%
Short Intervals
100%
Immunosuppressed Individuals
100%
Immunocompromised Patients
80%
Vaccination Schedule
80%
Immunization
40%
Patient Demographics
20%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
20%
Adverse Effects
20%
Viral Infection
20%
Dialysis Patients
20%
Hepatitis B Surface Antigen (HBsAg)
20%
Immunization Schedule
20%
High-dose Influenza Vaccine
20%
Immunosuppressed Population
20%
Immunology and Microbiology
Hepatitis B Virus
100%
Drug Megadose
100%
Antibody Response
100%
Vaccination Schedule
66%
Normal Human
33%
Viral Disease
16%
Hepatitis B Surface Antibody
16%
Hematopoietic Cell
16%
Medicine and Dentistry
Drug Megadose
100%
Antibody Response
100%
Hepatitis B Virus
100%
Virus Infection
16%
Hematopoietic Cell
16%
Patient Population
16%
Hepatitis B Antibody
16%
Adverse Effect
16%
Nursing and Health Professions
Drug Megadose
100%
Hepatitis B
100%
Vaccination Schedule
66%
Patient Population
16%
Virus Infection
16%
Hepatitis B Antibody
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B Virus
100%
Normal Human
40%
Virus Infection
20%
Hepatitis B Antibody
20%
Veterinary Science and Veterinary Medicine
Hepatitis B
100%
Hematopoietic Cell
20%
Virus Infection
20%